These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35436817)

  • 21. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
    Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
    Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the Self-reported After Events Following Immunization of COVID-19 Vaccines in Turkey and Bangladesh.
    Sultana A; Mim SR; Saha A; Yesmin F; Tahsin MR; Bahar NB; Fatema KR; Shahriar S; Prattay KMR; Rabbi F; Noushin F; Samodder M; Sadia QA; Ferdous J; Mamun MAH; Uddin MI; Akter T; Rahman MM; Sarker MMR; Kuddus MR; Aktar F; Chowdhury JA; Chowdhury AA; Kabir S; Büyüker SM; Rahman MS; Rahman MH; Amran MS
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):47381-47393. PubMed ID: 36738411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.
    Bhandari B; Rayamajhi G; Lamichhane P; Shenoy AK
    Biomed Res Int; 2022; 2022():2911333. PubMed ID: 36017393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial Intelligence-Enabled Social Media Analysis for Pharmacovigilance of COVID-19 Vaccinations in the United Kingdom: Observational Study.
    Hussain Z; Sheikh Z; Tahir A; Dashtipour K; Gogate M; Sheikh A; Hussain A
    JMIR Public Health Surveill; 2022 May; 8(5):e32543. PubMed ID: 35144240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study.
    Najjar M; Albuaini S; Fadel M; Mohsen F; ; Najjar G; Assaf D; Aljbawi A; AlAwad Y
    Ann Med; 2023; 55(2):2241351. PubMed ID: 37544017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.
    Mangat HS; Rippon B; Reddy NT; Syed AA; Maruthanal JM; Luedtke S; Puthumana JJ; Srivatsa A; Bosman A; Kostkova P
    PLoS One; 2023; 18(2):e0281993. PubMed ID: 36800368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
    Duijster JW; Lieber T; Pacelli S; Van Balveren L; Ruijs LS; Raethke M; Kant A; Van Hunsel F
    Front Immunol; 2023; 14():1078736. PubMed ID: 36793715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccine-related adverse events following immunization in the WHO Western Pacific Region, 2021-2022.
    Amarasinghe A; Cho H; Katalbas ER; Takashima Y
    Western Pac Surveill Response J; 2023; 14(2):1-11. PubMed ID: 37492235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
    Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D
    Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognizance, adverse effects and motivation regarding COVID-19 vaccination amongst health care professionals: A cross-sectional study.
    Sachdeva S; Saluja H; Mani A
    Dent Med Probl; 2022; 59(1):13-19. PubMed ID: 35119228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
    Qamar FN; Yousafzai MT; Khaliq A; Karim S; Memon H; Junejo A; Baig I; Rahman N; Bhurgry S; Afroz H; Sami U
    Vaccine; 2020 Apr; 38(19):3518-3523. PubMed ID: 32201138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.
    Chen M; Yuan Y; Zhou Y; Deng Z; Zhao J; Feng F; Zou H; Sun C
    Infect Dis Poverty; 2021 Jul; 10(1):94. PubMed ID: 34225791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
    Gordon SF; Virah Sawmy E; Duckworth E; Wolthuizen M; Clothier HJ; Chea M; Tenneti N; Blow N; Buttery JP; de Luca J; Korman TM; Barnes S; Slade C; Maggs C; Giles ML; Teh BW; Aboltins C; Langan KM; Van Diemen A; Crawford NW
    Hum Vaccin Immunother; 2022 Nov; 18(5):2052701. PubMed ID: 35471988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes following COVID-19 vaccination and associated factors among healthcare professionals in Oromia region, Ethiopia.
    Terefa DR; Shama AT; Tekle E
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167901. PubMed ID: 36703523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.